HALOZYME THERAPEUTICS, INC. (HALO)

Import this data to Google Sheets with:

=jivedata("HALO","financials")

Full statements spill as a table. For one cell: =jivedata("HALO","Revenue") or =jivedata("HALO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

HALOZYME THERAPEUTICS, INC.

HALO • CIK 0001159036

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Operating Income (Loss)	$337,574	$551,475	$469,006	$597,201
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$348,329	$557,132	$466,875	$583,338
Income Tax Expense (Benefit)	$66,735	$113,041	$149,986	$169,742
Net Income (Loss) Attributable to Parent	$281,594	$444,091	$316,889	$413,596
Revenue from Contract with Customer, Excluding Assessed Tax	$829,253	$1,015,324	$1,396,611	$1,663,738
Cost of Goods and Services Sold	$192,361	$159,417	$228,774	$292,421
Amortization of Intangible Assets	$73,773	$71,049	$76,662	$100,162
Research and Development Expense (Excluding Acquired in Process Cost)	—	—	$81,490	$81,490
Selling, General and Administrative Expense	$149,182	$154,335	$207,092	$237,995
Impairment of Intangible Assets (Excluding Goodwill)	—	—	$48,700	$48,700
Research and Development Asset Acquired Other than Through Business Combination, Written-off	—	—	$284,887	$284,887
Costs and Expenses	$491,679	$463,849	$927,605	$1,066,537
Other Nonoperating Income (Expense)	$16,317	$23,752	$21,472	$11,917
Induced Conversion of Convertible Debt Expense	$0	$0	$5,477	$5,477
InterestExpenseNonoperating	—	$18,095	$18,126	$20,303
Weighted Average Number of Shares Outstanding, Basic	131,927,000	126,827,000	119,840,000	115,273,000
Weighted Average Number of Shares Outstanding, Diluted	134,197,000	129,424,000	123,904,000	120,544,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	27,800,000	26,100,000	24,600,000	28,500,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$118,370	$115,850	$133,820	$163,138
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent	$217,630	$480,224	$9,000	$67,865
Prepaid Expense and Other Assets, Noncurrent	$17,816	$80,596	$53,551	$55,090
Inventory, Net	$127,601	$141,860	$176,475	$137,135
Goodwill	$416,821	$416,821	$580,360	$581,732
Prepaid Expense and Other Assets, Current	$48,613	$38,951	$64,639	$109,059
Intangible Assets, Net (Excluding Goodwill)	$472,879	$401,830	$981,467	$922,443
Assets, Current	$746,424	$1,085,340	$825,207	$933,024
Deferred Income Tax Assets, Net	$4,386	$3,855	$0	$0
Restricted Cash and Cash Equivalents, Noncurrent	$0	—	$2,601	$848
Assets	$1,733,270	$2,063,477	$2,525,323	$2,577,408
Long-term Debt, Excluding Current Maturities	$1,499,248	$1,505,798	$2,142,630	$1,937,684
Other Liabilities, Noncurrent	$37,720	$54,758	$113,863	$102,681
Deferred Income Tax Liabilities, Net	—	—	$42,924	$49,061
Liabilities	$1,649,462	$1,699,656	$2,476,509	$2,433,865
Accounts Payable, Current	$11,816	$10,249	$20,899	$23,608
Accrued Liabilities, Current	$100,678	$128,851	$156,193	$111,861
Liabilities, Current	$112,494	$139,100	$177,092	$344,439
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$127	$123	$118	$114
Additional Paid in Capital, Common Stock	$2,409	$0	$12,002	$0
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-9,278	$3,829	$-18,092	$-7,830
Retained Earnings (Accumulated Deficit)	$90,550	$359,869	$54,786	$151,259
Stockholders' Equity Attributable to Parent	$83,808	$363,821	$48,814	$143,543
Preferred Stock, Shares Authorized	20,000,000	20,000,000	20,000,000	20,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	126,770,000	123,138,000	117,782,000	114,042,000
Contract with Customer, Asset, before Allowance for Credit Loss, Current	$956	$20,251	$15,000	$2,500
Inventory, Raw Materials, Net of Reserves	$23,646	$24,015	$21,869	$21,401
Inventory, Work in Process, Net of Reserves	$34,025	$30,169	$30,920	$39,395
Inventory, Finished Goods, Net of Reserves	$69,930	$142,944	$144,454	$91,178
Inventory, Noncurrent	—	$55,268	$20,768	$14,839
Prepaid Expense, Current	$36,850	$36,317	$71,925	$75,285
Other Prepaid Expense, Current	$12,902	$10,562	$14,563	$44,768
Other Assets	$16,677	$17,400	$10,934	$17,670
Prepaid Expense and Other Assets	$66,429	$119,547	$118,190	$164,149
Property, Plant and Equipment, Gross	$57,769	$66,293	$77,601	$83,700
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$19,661	$25,429	$33,159	$33,936
Property, Plant and Equipment, Net	$38,108	$40,864	$44,442	$49,764
Operating Lease, Right-of-Use Asset	$36,836	$34,171	$37,695	$34,507
Depreciation, Depletion and Amortization	$11,083	$10,263	$11,389	$8,676
Operating Lease, Right-of-Use Asset, Amortization Expense	—	$5,700	$6,500	$5,100
Operating Lease, Cost	$8,000	$7,900	$8,700	$6,300
Operating Lease, Payments	$6,700	$6,900	$7,700	$5,900
Employee-related Liabilities	—	$24,400	$28,621	$20,684
Taxes Payable	$963	$30,995	$44,148	$44,148
Contract with Customer, Refund Liability	$41,932	$54,588	$46,594	$44,108
Other Accrued Liabilities	—	$26,239	$104,349	$86,264
Operating Lease, Liability	$32,197	$30,705	$34,569	$31,879
Accrued Liabilities and Other Liabilities	$138,398	$183,609	$270,056	$214,542

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-116,325	$-2,520	$20,571	$102,125
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$118,370	$115,850	$136,421	$272,102
Net Income (Loss) Attributable to Parent	$281,594	$444,091	$316,889	$413,596
Net Cash Provided by (Used in) Operating Activities	$388,571	$479,064	$651,558	$818,595
Payments to Acquire Debt Securities, Available-for-sale	$292,911	$647,601	$247,355	$125,561
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	$211,296	$395,574	$722,248	$722,248
Payments to Acquire Businesses, Net of Cash Acquired	$0	$0	$725,965	$725,965
Payments to Acquire Property, Plant, and Equipment	$15,294	$10,696	$6,970	$12,371
Net Cash Provided by (Used in) Investing Activities	$-96,909	$-262,723	$-545,813	$-605,719
Repayments of Convertible Debt	$13,483	$0	—	$0
Proceeds from Convertible Debt	$0	$0	—	$0
Payments of Debt Issuance Costs	$0	$0	$4,938	$4,938
Payments for Repurchase of Common Stock	$402,383	$250,000	$342,372	$371,612
Net Cash Provided by (Used in) Financing Activities	$-407,987	$-218,861	$-85,174	$-110,751
Cash and Cash Equivalents, at Carrying Value	$118,370	$115,850	$133,820	$267,241
Restricted Cash and Cash Equivalents, Noncurrent	$0	—	$2,601	$4,861
Interest Paid, Excluding Capitalized Interest, Operating Activities	$11,410	$10,565	$11,429	$11,429
Income Taxes Paid, Net	$31,756	$80,618	$134,641	$134,641
Capital Expenditures Incurred but Not yet Paid	$25	$280	$902	$2,993
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$2,572	$3,078	$410	$1,623
Stock Issued	$125	$0	$0	$0
Share-based Payment Arrangement, Noncash Expense	$36,620	$43,385	$51,565	$63,066
Depreciation, Depletion and Amortization	$11,083	$10,263	$11,389	$14,638
Amortization of Intangible Assets	$73,773	$71,049	$76,662	$100,162
Amortization of Debt Discount (Premium)	$7,304	$7,350	$7,506	$8,307
Accretion (Amortization) of Discounts and Premiums, Investments	$6,319	$10,918	$3,296	$1,085
Debt Securities, Available-for-sale, Realized Gain (Loss)	$0	$7	$171	$169
Gain (Loss) on Disposition of Property Plant Equipment	$-611	$-1,529	$-2,621	$-2,697
Induced Conversion of Convertible Debt Expense	$0	$0	$5,477	$5,477
Increase (Decrease) in Deferred Income Taxes	$-34,506	$-532	$-634	$-14,921
Research and Development Asset Acquired Other than Through Business Combination, Written-off	—	—	$284,887	$284,887
Impairment of Intangible Assets (Excluding Goodwill)	—	—	$48,700	$48,700
Increase (Decrease) in Accounts Receivable	$3,339	$74,245	$128,063	$137,564
Increase (Decrease) in Inventories	$26,884	$67,381	$-2,554	$-63,391
Increase (Decrease) in Prepaid Expense and Other Assets	$-4,098	$-5,356	$32,958	$42,151
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$-12,546	$46,993	$6,211	$-21,148

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("HALO","financials")

Full statements spill as a table. For one cell: =jivedata("HALO","Revenue") or =jivedata("HALO","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.